AngioDynamics Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by AngioDynamics, Inc. on August 24, 2011, covering events occurring on August 19, 2011. The company is incorporated in Delaware and maintains its principal executive offices in Queensbury, New York.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a corporate governance event and contains no financial data.
Material Changes
The material change reported is the resignation of Lynda Wallace from her position as Senior Vice President of Business Development. Her resignation is effective September 16, 2011.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items beyond the executive departure.
Key Facts for Investor Verification
- Lynda Wallace resigned as Senior Vice President of Business Development.
- The effective date of the resignation is September 16, 2011.
- The report was signed by D. Joseph Gersuk, Chief Financial Officer.